300 EAST MAIN STREET, SUITE 201, CHARLOTTESVILLE, VA, 22902
Showing data for
Sector / Industry: | Healthcare / Biotechnology | ||
Total Shares: | 8,253,741 | Market Cap: | $19.3 mn |
Shares Held by Institutions1 : | 1,362,027 | Institutional %: | 16.50 % |
Shareholder Base Turnover2 : | 3.38 % | Concentration of Institutional Shareholder Base3 : | 15.48 % |
Percentage Initiated in Last One Year4 : | 68.02 % | Percentage Initiated in Last Two Years4 : | 68.1 % |
Number of Hedge Funds: | 3 | Percentage Held by Hedge Funds: | 7.64 % |
Notes:
Showing data for
Fund | Title of Class | Value ($mm) | Actions |
---|
Rank | Name | Options | Total | Shares O/S (%) | Dollar Value ($mm) | Current Dollar Value ($mm) | Previously Owned | Position Initiated Period | Quality | Value | Small Size | Volatility | Momentum | Dividend | Revenue Growth (YoY) | Revenue Growth (3 Yrs) | Portfolio % | Portfolio Position | Fund Size ($mm) | Change | Est. Cost Basis | Est. Gain / Loss % | Qtr End Gain / Loss % | Investor Type | Classification | Peers Held | Actions |
---|
Name | Last Reported On | Total | Position Initiated Period | Number of Quarters Held | Portfolio Percentage | Portfolio Position | Est. Cost Basis | Est. Gain / Loss % | Actions |
---|
Fund Name | Previous. Num. Shares | Difference | Num. Shares | Previous Dollar Value ($mm) | Dollar Value Difference ($mm) | Current Dollar Value ($mm) | Position Initiated | Est. Cost Basis | Est. Gain / Loss | Actions |
---|
** - Stocks bought during IPO
Fund Name | Previous. Num. Shares | Difference | Num. Shares | Previous Dollar Value ($mm) | Dollar Value Difference ($mm) | Current Dollar Value$($mm) | Position Initiated | Actions |
---|
Rank | Name | Fund Types | Index Fund | Fund Ticker | Advisors | Reporting Period | Portfolio Percentage | Company Percentage | Number of Shares | Value ($ mn) | Classification | Net Assets ($ mn) | Quality | Value | Small Size | Volatility | Momentum | Dividend | Revenue Growth (YoY) | Revenue Growth (3 Yrs) | Actions |
---|
Rank | Name | Fund Types | Reporting Period | Portfolio Percentage | Company Percentage | Number of Shares | Value ($ mn) | Net Assets ($ mn) | Actions |
---|
Fund | Q1-2016 | Q2-2016 | Q3-2016 | Q4-2016 | Q1-2017 | Q2-2017 | Q3-2017 | Q4-2017 | Q1-2018 | Q2-2018 | Q3-2018 | Q4-2018 | Q1-2019 | Q2-2019 | Q3-2019 | Q4-2019 | Q1-2020 | Q2-2020 | Q3-2020 | Q4-2020 | Q1-2021 | Q2-2021 | Q3-2021 | Q4-2021 | Q1-2022 | Q2-2022 | Q3-2022 | Q4-2022 | Q1-2023 | Q2-2023 | Q3-2023 | Q4-2023 | Q1-2024 | Q2-2024 | Q3-2024 | Q4-2024 | Current Number of Shares | Actions |
---|